| Literature DB >> 32416578 |
Vincent Gatinois1, Romain Desprat2, Lydiane Pichard3, Fabienne Becker2, Alice Goldenberg4, Xavier Balguerie5, Franck Pellestor6, Jean-Marc Lemaitre7.
Abstract
Rothmund-Thomson Syndrome (RTS) is a rare autosomal recessive disease that manifests several clinical features of accelerated aging. These findings include atrophic skin and pigment changes, alopecia, osteopenia, cataracts, and an increased incidence of cancer for patients. Mutations in RECQL4 gene are responsible for cases of RTS. RECQL4 belongs to the RECQ DNA helicase family which has been shown to participate in many aspects of DNA metabolism. To be able to study the cellular defects related to the pathology, we derived an induced pluripotent cell line from RTS patient fibroblasts, with the ability to re-differentiate into the three embryonic germ layers.Entities:
Mesh:
Year: 2020 PMID: 32416578 DOI: 10.1016/j.scr.2020.101807
Source DB: PubMed Journal: Stem Cell Res ISSN: 1873-5061 Impact factor: 2.020